ResearchMoz

Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

Publisher Name » GBI Research
Published Date » 2012-12-14
No. Of Pages » 49

Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes

Summary

GBI Research, the leading business intelligence provider, has released its latest research report: Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes. The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes.

It looks in detail at the ways in which the pharmaceutical industry has utilized mobile technologies in patient recruitment, compliance and retention of clinical trials, its role in marketing and consumer education and the important developments in drug authentication and post-market surveillance.

The report investigates how the healthcare system has migrated from a paper-based system to an electronic one and the innovative ways in which this can be used enhance the flow of medical information. It assesses the growing use of mobile health apps as reference and diagnostic tools to support decision-making and highlights how mHealth can improve communication between patients and healthcare providers; empowering patients to take a more active role in their health and improving the continuum of healthcare from the clinic to the home.

Lastly, the report examines how mHealth programs in the emerging economies and the developed world can help to bridge the gap within fragmented under-resourced healthcare systems. It highlights how technologies devised for the developed countries are not always suitable for the developing countries and the need for local communities to devise mHealth solutions to address local issues such as infectious diseases (dengue fever, AIDS/HIV and tuberculosis) and high infant and maternal mortality rates.

The report is built using information from primary and secondary research including interviews with experts in the field.

GBI Researchs analysis concludes that mHealth has huge potential to bridge the gap within existing healthcare systems but highlights the significant differences in the rate of adoption of mHealth in the developed world compared to the developing countries due to their existing infrastructures and differing doctor-centric and patient centric approaches to healthcare.

The mHealth alliance has identified five critical areas that need to be addressed if mHealth is to become main stream in global health: evidence building, standards and interoperability, sustainable financing, capacity building and policy. This will only be achieved if all stakeholders (patients, healthcare professionals and providers, pharmaceutical industry, mobile network operators and governments) work together to determine the ways in which mHealth can add value and provide significant advantages over traditional routes of healthcare communication.

Scope

  • Detailed analysis of how the pharmaceutical industry is applying mHealth in clinical trials, marketing and supply chain management
  • Assessment of the e-patient engagement strategies that healthcare providers (medical professional, clinicians pharmacists and health insurers) are adopting to improve communication with patients
  • Exploration of the role of mobile health tools in supporting physicians decision-making and prescribable apps to support patient healthcare requirements
  • Explorations of the key challenges facing the adoption of mHealth in the developed world and emerging economies
  • Case studies of mHealth programs and solutions in trial recruitment, supply chain management, decision support tools, education and awareness programs and many more

Reasons to buy

  • Identify key stakeholders and the role they play in the development of mHealth solutions
  • Understand what mHealth services are available and how and where they are being utilized
  • Learn the barriers to implementation and how these may be overcome
  • Understand current thinking on innovative areas of mHealth and its application by the pharmaceutical industry
  • Identify potential opportunities for mHealth solutions by healthcare providers
  • Explore the current mHealth programs and assess the ways these may be translated in other areas of the world
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 What is mHealth? 7
2.2 mHealth Aims 8
2.3 Stakeholder Groups Involved in the Funding and Provision of mHealth 9
2.4 Role of mHealth Technologies in the Pharmaceutical Industry 10
2.5 Key Market Segments in the mHealth Space 10
2.5.1 Mobile Health - Mobile Network Operators 10
2.5.2 Mobile Health - Pharmaceutical Industry 10
2.5.3 Mobile Health - Healthcare Professionals 11
2.5.4 Mobile Health - Healthcare Providers 11
2.5.5 Mobile Health - Consumers 11

3 mHealth in Drug Development 12
3.1 Introduction 12
3.2 Mobile Health in Pharmaceutical R&D 13
3.3 Patient Recruitment in Clinical Trials 14
3.3.1 Case Study: REMOTE (Pfizer) 14
3.3.2 Social Media 14
3.4 Patient Compliance and Retention in Clinical Trials 16
3.5 Safety Data Collection 17
3.6 Consumer Education 18
3.7 Mobile Medical Education 18
3.8 Drug Authentication 19
3.9 Post-market Surveillance 20

4 mHealth in Healthcare 21
4.1 Introduction 21
4.2 Electronic Personal Health Records 21
4.3 Electronic Health Records and Medical Records 22
4.3.1 Electronic Health Records and Observational Studies 22
4.4 Clinical Decision Support Systems 23
4.4.1 Case Study: Epocrates 23
4.5 Mobile Healthcare for Healthcare Providers 24
4.5.1 Prescribable Apps 25
4.5.2 Virtual Consultations 25
4.6 Recent Innovations in Medical Diagnostics 26
4.7 Barriers to mHealth Implementation 27

5 Transforming Healthcare in the Emerging Economies through mHealth 28
5.1 Introduction 28
5.2 Shortage of Medical Resources 29
5.3 Improving the Flow of Health Information 30
5.4 Role of the mHealth Alliance 31
5.5 mHealth Applications in the Emerging Economies 32
5.6 Disease Surveillance 33
5.7 Education and Awareness 35
5.7.1 Mobile Technology for Community Health 35
5.7.2 iTEACH 35
5.8 Healthcare Information Management Systems 37
5.9 Health Financing 38
5.10 Patient Monitoring and Support 38
5.11 Point-of-care Services 40
5.12 Barriers to mHealth Implementation in the Emerging Economies 42
5.13 Overall Conclusions 42

6 Appendix 43
6.1 Acronyms 43
6.2 Bibliography 44
6.3 Terminology 48
6.4 Methodology 48
6.4.1 Primary Research 48
6.4.2 Secondary Research 49
6.5 Contact Us 49
6.6 Disclaimer 49

List of Tables


Table 1: mHealth Disease Surveillance Programs 34
Table 2: mHealth Education and Awareness Programs 36
Table 3: mHealth Health Information Management Systems Programs 37
Table 4: mHealth Patient Monitoring and Support Programs 38
Table 5: mHealth Point-of-care Programs 41

List of Figures


Figure 1: mHealth Services 7
Figure 2: Key Stakeholders in the Provision of Funding to Drive mHealth Forward 9
Figure 3: Potential Application of mHealth by the Pharmaceutical Industry 13
Figure 4: Impact of Social Media on Phase III Recruitment of Diabetic Neuropathy Trial, 2011 15
Figure 5: Exco InTouch Services 16
Figure 6: PharmaSecure Drug Authentication Mobile App 19
Figure 7: Innovative Healthcare Software Platforms 20
Figure 8: Mobile Patient Communication Software 24
Figure 9: Patient Perception of how mHealth will Change Healthcare 28
Figure 10: Cell phone Subscriptions per 100 Inhabitants, 2001-2011 29
Figure 11: mHealth Applications in the Emerging Economies 30
Figure 12: mHealth Initiatives in Member States, by WHO region, 2011 32

Upcoming Reports:

Fertilizer Mixtures Market- Global Forecast, Market Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Two or more fertilizers are mixed in some proportion to produce two or three major elements such as Nitrogen (N), Phosphorus pentoxide (P2O5) and Potassium oxide (K2O) which helps in the effective growth of soil and food. The fertilizer mixtures shipped in 2008 were USD 2.7 billion which was approximately the same as in 2002 due to the fact that single nutrient fertilizers have dominated the fertilizers market during the past 30 years.  Someof the major factors driving the fertilizer mixtures market are that it increases the soil efficiency and decreases the operating...
Pain Management Therapeutics Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
More than 1.5 billion people around the world suffer from chronic pain and it is one of the leading causes of patients seeking medical care. Moreover, cost of pain comes to around USD 100 billion per year which includes lost workdays and medical bills. The global pain management therapeutics has observed healthy growth rate in the past and has huge market potential in the future due to increase in the number of population that suffers from medically significant pain. Other drivers for this market include pain related to different tumors, low back and post- operation. The expiry patent...
Personal Hygiene Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The personal hygiene market is growing significantly owing to the increasing interest of people for personal care and health concerns. Many new manufacturers are making their way into the market as a result of the rising trend of personal care products in growing economies.  Personal hygiene is the first step toward good grooming and better health. There are a variety of illnesses that can be prevented just by improving personal hygiene. Some illnesses are not a result of poor personal hygiene, but improving the standards of hygiene will control adverse conditions. ...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...